A. Saral Et Al. , "Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation," JOURNAL OF ANTIBIOTICS , vol.69, no.12, pp.858-862, 2016
Saral, A. Et Al. 2016. Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation. JOURNAL OF ANTIBIOTICS , vol.69, no.12 , 858-862.
Saral, A., Leonard, D. A., Duzgun, A. O., Cicek, A., June, C. M., & SANDALLI, C., (2016). Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation. JOURNAL OF ANTIBIOTICS , vol.69, no.12, 858-862.
Saral, Aysegul Et Al. "Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation," JOURNAL OF ANTIBIOTICS , vol.69, no.12, 858-862, 2016
Saral, Aysegul Et Al. "Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation." JOURNAL OF ANTIBIOTICS , vol.69, no.12, pp.858-862, 2016
Saral, A. Et Al. (2016) . "Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation." JOURNAL OF ANTIBIOTICS , vol.69, no.12, pp.858-862.
@article{article, author={Aysegul Saral Et Al. }, title={Kinetic characterization of GES-22 beta-lactamase harboring the M169L clinical mutation}, journal={JOURNAL OF ANTIBIOTICS}, year=2016, pages={858-862} }